CIK 0001651308 · Large accelerated filer
BeOne Medicines Ltd.
Sign in to watch- Ticker
- BEIGF
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981209416
- Phone
- 41-616851900
- Business address
- C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
- Former names
- BeiGene, Ltd.
Securities
- ONC American Depositary Shares Nasdaq
- BEIGF Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $48,487,541
- in 9 filings, $47.8M under 10b5-1 plans
Net −$48,487,541. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-07-21 | OYLER JOHN Chief Executive Officer | Sale 10b5-1 | −7,842 | $318.41 | $2.5M | 18,147 |
| 2026-07-21 | OYLER JOHN Chief Executive Officer | Sale 10b5-1 | −15,807 | $319.29 | $5.0M | 2,340 |
| 2026-07-21 | OYLER JOHN Chief Executive Officer | Sale 10b5-1 | −2,340 | $320.06 | $749K | 0 |
| 2026-07-20 | OYLER JOHN Chief Executive Officer | Sale 10b5-1 | −5,146 | $310.08 | $1.6M | 9,180 |
| 2026-07-20 | OYLER JOHN Chief Executive Officer | Sale 10b5-1 | −6,273 | $310.75 | $1.9M | 2,907 |
| 2026-07-20 | OYLER JOHN Chief Executive Officer | Sale 10b5-1 | −2,907 | $311.80 | $906K | 0 |
| 2026-07-20 | OYLER JOHN Chief Executive Officer | Option exercise 10b5-1 | +33,990 | $119.96 | $4.1M | 33,990 |
| 2026-07-20 | OYLER JOHN Chief Executive Officer | Sale 10b5-1 | −15,499 | $312.29 | $4.8M | 18,491 |
| 2026-07-20 | OYLER JOHN Chief Executive Officer | Sale 10b5-1 | −14,326 | $312.96 | $4.5M | 4,165 |
| 2026-07-20 | OYLER JOHN Chief Executive Officer | Sale 10b5-1 | −1,850 | $313.91 | $581K | 2,315 |
| 2026-07-20 | OYLER JOHN Chief Executive Officer | Sale 10b5-1 | −1,512 | $315.26 | $477K | 803 |
| 2026-07-20 | OYLER JOHN Chief Executive Officer | Sale 10b5-1 | −523 | $316.14 | $165K | 280 |
| 2026-07-20 | OYLER JOHN Chief Executive Officer | Sale 10b5-1 | −280 | $318.30 | $89K | 0 |
| 2026-07-20 | OYLER JOHN Chief Executive Officer | Option exercise · Share Option (Right to Buy) 10b5-1 | −441,870 | 0 | ||
| 2026-07-17 | OYLER JOHN Chief Executive Officer | Option exercise 10b5-1 | +64,628 | $119.96 | $7.8M | 64,628 |
| 2026-07-17 | OYLER JOHN Chief Executive Officer | Sale 10b5-1 | −1,440 | $305.20 | $439K | 63,188 |
| 2026-07-17 | OYLER JOHN Chief Executive Officer | Sale 10b5-1 | −597 | $306.96 | $183K | 62,591 |
| 2026-07-17 | OYLER JOHN Chief Executive Officer | Sale 10b5-1 | −680 | $309.05 | $210K | 61,911 |
| 2026-07-17 | OYLER JOHN Chief Executive Officer | Sale 10b5-1 | −4,833 | $310.37 | $1.5M | 57,078 |
| 2026-07-17 | OYLER JOHN Chief Executive Officer | Sale 10b5-1 | −5,543 | $311.42 | $1.7M | 51,535 |
Page 6 of 71 · 1,406 trades